Senicapoc clinical trials

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

This study looks into a new drug called Senicapoc for people with lung scarring diseases like pulmonary fibrosis. Researchers want to see if Senicapoc can stop the scarring from getting worse, compared to a dummy pill. It involves taking pills for 26 weeks and having check-ups.